NYSEMKT: NBYNovabay Pharmaceuticals Inc Stock Ownership - Who owns Novabay Pharmaceuticals?
Insider buying vs selling
Have Novabay Pharmaceuticals Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when NBY insiders and whales buy or sell their stock.
NBY Shareholders
What type of owners hold Novabay Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ramin Najafi | 291.48% | 19,031,699 | $5.61M | Insider |
| China Pioneer Pharma Holdings Ltd | 223.91% | 14,619,468 | $4.31M | Insider |
| Pioneer Pharma Hong Kong Co Ltd | 186.76% | 12,194,077 | $3.60M | Insider |
| Pioneer Pharma Singapore Pte Ltd | 79.46% | 5,188,421 | $1.53M | Insider |
| Jian Ping Fu | 61.26% | 4,000,000 | $1.18M | Insider |
| Xinzhou Li | 42.91% | 2,801,743 | $826.51k | Insider |
| Naqu Area Pioneer Pharma Co Ltd | 42.88% | 2,800,000 | $826.00k | Insider |
| Mark M. Sieczkarek | 17.72% | 1,156,883 | $341.28k | Insider |
| Robert R. Tufts | 15.58% | 1,017,066 | $300.03k | Insider |
| Anthony Dailley | 14.04% | 917,035 | $270.53k | Insider |
NBY vs Biotech Stocks
Novabay Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.